As a result of a partnership between Nantes University Hospital and the Western Cancer Institute (ICO), the new shared medical imaging centre, IMRAM, opened on 3 May 2021. Two new equipments have [...]
ILIAD brings together medical, scientific and technological expertise while combining different disciplines (nuclear medicine, oncology, hematology, biological sciences, human and social sciences, epidemiology, chemistry, physics and mathematics) within a consortium of 9 research laboratories, 3 health establishments and 27 high level technological platforms.
ILIAD is underpinned by integrated research, which is innovative and multidisciplinary, structured around heterogeneity and tumour resistance. Articulated around the care pathway, the research carried out by the ILIAD teams also relates to the life of the patients by integrating the issues of social inequality and how to retain a job when faced with illness.
The research programmes are represented by two tumours which have been chosen as demonstrators: multiple myeloma and breast cancer.